Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimasertib + Voxtalisib in Low-Grade Ovarian Cancer
NCT01936363Phase 2Completed
- Sponsor
- EMD Serono
- Start
- Sep 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of voxtalisib in Low grade serous ovarian cancer (LGSOC), sponsored by EMD Serono. Started Sep 2013; status: completed.
02
Drugs
voxtalisib
03
Conditions
Low grade serous ovarian cancer (LGSOC)
Beyond the preview
Go deeper on NCT01936363.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01936363.